about
Mechanisms underlying the inhibitory effects of arsenic compounds on protein tyrosine phosphatase (PTP).[Cellular distribution and behavior of metallothionein in mammalian cells following exposure to silver nanoparticles and silver ions].Bioavailability Comparison of Nine Bioselenocompounds In Vitro and In Vivo.Mitochondria are the main target organelle for trivalent monomethylarsonous acid (MMA(III))-induced cytotoxicity.Changes in intracellular copper concentration and copper-regulating gene expression after PC12 differentiation into neurons.Orthogonality of calcium concentration and ability of 4,5-diaminofluorescein to detect NO.Selenium metabolism in rats with long-term ingestion of Se-methylselenocysteine using enriched stable isotopes.Preparation of envelope-type lipid nanoparticles containing gold nanorods for photothermal cancer therapy.Identification and determination of selenohomolanthionine - The major selenium compound in Torula yeast.Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy.Mutagenicity comparison of nine bioselenocompounds in three Salmonella typhimurium strains.Casein kinase 2 promotes interaction between Rad17 and the 9-1-1 complex through constitutive phosphorylation of the C-terminal tail of human Rad17Development of a new doubly-labeled fluorescent ceramide probe for monitoring the metabolism of sphingolipids in living cellsEffect of administration route and dose on metabolism of nine bioselenocompounds.Remarkable axial thiolate ligand effect on the oxidation of hydrocarbons by active intermediate of iron porphyrin and cytochrome P450A new thioether-ligated iron porphyrin as a model of a protonated form of P450 active siteRapid speciation and quantification of selenium compounds by HPLC-ICP MS using multiple standards labelled with different isotopesEnantioselective construction of a polyhydroxylated pyrrolidine skeleton from 3-vinylaziridine-2-carboxylates: synthesis of (+)-DMDP and a potential common intermediate for (+)-hyacinthacine A1 and (+)-1-epi-australineUnprecedented 8,9'-neolignans: enantioselective synthesis of possible stereoisomers for structural determination
P50
Q34330006-AAB56426-1C4F-49DA-8FF4-0F7665D7B3C6Q35177418-D326CF50-F4C1-4F2B-8D3F-41D161ED5C02Q37729029-DE998606-98FA-4C20-BFCE-F7FA7C64EC67Q39529265-0F434F35-739B-400D-8984-A55DD079397EQ41074982-E95E548B-A336-4269-844F-FD7AFE3F52CCQ43771460-096188AF-5ACD-4085-920E-19BDD387E699Q46066401-4B14E46F-211F-472E-AFC8-0595C0E13DCCQ47440896-5493EE02-AE7A-48D4-B4BD-9E17C1F4F991Q48003942-D958AAE3-08AD-4891-8E1B-F99B99ECE6C7Q50353096-4AB896E6-9566-44B2-B100-C31A70C877D2Q54940560-06B0F970-9F65-48EC-B40C-5B7D71463FF2Q57044107-93968C6B-E4F2-4244-8281-5F466000205EQ57461612-E8CA492F-0CC3-4A4F-B670-9D56AB32B790Q64998861-3FD4F5EC-4176-445D-9443-4A9BA9BE943CQ73333527-E6D062B8-5359-47D2-83A6-561519A70566Q73333532-CBDD7D81-EB38-4093-810C-7403E53907B9Q84558660-22806936-B24D-45E1-A66B-0BD290956B01Q84809185-ACD267C7-3C16-41BA-9B20-601A734C0E41Q86062402-C7EDE995-4B87-415C-8CA9-54F3C40EF9C8
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Noriyuki Suzuki
@ast
Noriyuki Suzuki
@en
Noriyuki Suzuki
@es
Noriyuki Suzuki
@nl
type
label
Noriyuki Suzuki
@ast
Noriyuki Suzuki
@en
Noriyuki Suzuki
@es
Noriyuki Suzuki
@nl
prefLabel
Noriyuki Suzuki
@ast
Noriyuki Suzuki
@en
Noriyuki Suzuki
@es
Noriyuki Suzuki
@nl
P108
P1153
55577141500
P31
P496
0000-0002-9345-6335